2023 Annual Meeting | C46 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia
01:00 PM - 01:35 PM EST | Speaker |
Nonpharmacological Treatment of Behavioral Symptoms in Dementia
Julio C. Rojas-Martinez, MD, PhD |
01:35 PM - 02:10 PM EST | Speaker |
Pharmacological Treatment of Cognitive and Behavioral Symptoms in Dementia
Lealani M. Acosta, MD, MPH, FAAN |
02:10 PM - 02:45 PM EST | Speaker |
Disease Modifying Therapeutics in Dementia
Meredith Wicklund, MD, FAAN |
02:45 PM - 03:00 PM EST | Discussion |
Questions and Answers
Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD, Lealani M. Acosta, MD, MPH, FAAN |
Meredith Wicklund, MD, FAAN | The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH. |
Julio C. Rojas-Martinez, MD, PhD | The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. Dr. Rojas-Martinez has received research support from Roon, Healthcare. The institution of Dr. Rojas-Martinez has received research support from Amylyx. |
Lealani M. Acosta, MD, MPH, FAAN | Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH. |